Literature DB >> 11907210

Parameters of human hepatitis delta virus genome replication: the quantity, quality, and intracellular distribution of viral proteins and RNA.

Severin Gudima1, Jinhong Chang, Gloria Moraleda, Anna Azvolinsky, John Taylor.   

Abstract

Assembly of hepatitis delta virus (HDV) in infected human hepatocytes involves association of the 1,679- nucleotide single-stranded genomic RNA (deltaRNA) with multiple copies of both small and large forms of the delta protein (deltaAg) to form a ribonucleoprotein particle which in turn interacts with envelope proteins of the natural helper virus, hepatitis B virus. Subsequently, for initiation of a new round of replication, the amount of small deltaAg within the assembled HDV particle is both necessary and sufficient. Quantitative assays were used in order to better understand just how much deltaAg is needed. The molar ratio of deltaAg species to genomic deltaRNA in assembled HDV particles was approximately 200. Next, this ratio was determined for cells under several different experimental situations in which HDV genome replication was occurring. These included replication in woodchuck liver and also in mouse liver and skeletal muscle, as well as replication in stably and transiently transfected cultured human hepatoblastoma cells. Surprisingly, in almost all these situations the molar ratios were comparable to that observed for HDV particles. This was true for different times after the initiation of replication and was independent of whether or not virus assembly was occurring. Cell fractionation combined with quantitative assays was used to test whether the majority of deltaAg and deltaRNA were colocalized during HDV replication in transfected cells. The cytoplasmic fraction contained the majority of deltaAg and genomic deltaRNA. Finally, the quality of deltaAg and deltaRNA, especially at relatively late times after the initiation of replication, was examined by using reverse transcription-PCR, cloning, and sequencing through the entire deltaAg open reading frame. When virus assembly and spread were not possible, 20% or less of the predicted deltaAg would have been able to support HDV replication. In summary, an examination of the quantity, quality and intracellular distribution of deltaAg and deltaRNA in several different experimental systems has provided a better understanding of the parameters associated with the initiation, maintenance, and ultimate decline of HDV genome replication.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907210      PMCID: PMC136113          DOI: 10.1128/jvi.76.8.3709-3719.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases.

Authors:  L E Modahl; T B Macnaughton; N Zhu; D L Johnson; M M Lai
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  Replication of the human hepatitis delta virus genome Is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences.

Authors:  J Chang; L J Sigal; A Lerro; J Taylor
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Origin of hepatitis delta virus mRNA.

Authors:  S Gudima; S Y Wu; C M Chiang; G Moraleda; J Taylor
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

Authors:  M Rizzetto; M G Canese; S Aricò; O Crivelli; C Trepo; F Bonino; G Verme
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

5.  Hepatitis delta virus replication generates complexes of large hepatitis delta antigen and antigenomic RNA that affiliate with and alter nuclear domain 10.

Authors:  P Bell; R Brazas; D Ganem; G G Maul
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  Hepatitis delta virus minimal substrates competent for editing by ADAR1 and ADAR2.

Authors:  S Sato; S K Wong; D W Lazinski
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  Host RNA polymerase requirements for transcription of the human hepatitis delta virus genome.

Authors:  G Moraleda; J Taylor
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Structure, sequence and expression of the hepatitis delta (delta) viral genome.

Authors:  K S Wang; Q L Choo; A J Weiner; J H Ou; R C Najarian; R M Thayer; G T Mullenbach; K J Denniston; J L Gerin; M Houghton
Journal:  Nature       Date:  1986 Oct 9-15       Impact factor: 49.962

9.  Transmission of the hepatitis B virus-associated delta antigen to chimpanzees.

Authors:  M Rizzetto; M G Canese; J L Gerin; W T London; D L Sly; R H Purcell
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

10.  Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck.

Authors:  A Ponzetto; P J Cote; H Popper; B H Hoyer; W T London; E C Ford; F Bonino; R H Purcell; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

View more
  39 in total

Review 1.  Hepatitis delta virus: A fascinating and neglected pathogen.

Authors:  Celso Cunha; João Paulo Tavanez; Severin Gudima
Journal:  World J Virol       Date:  2015-11-12

2.  Reconstitution in cultured cells of replicating HDV RNA from pairs of less than full-length RNAs.

Authors:  Severin O Gudima; Jinhong Chang; John M Taylor
Journal:  RNA       Date:  2004-12-01       Impact factor: 4.942

3.  Evolution of hepatitis delta virus RNA genome following long-term replication in cell culture.

Authors:  Jinhong Chang; Severin O Gudima; John M Taylor
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Assembly of hepatitis delta virus: particle characterization, including the ability to infect primary human hepatocytes.

Authors:  Severin Gudima; Yiping He; Anja Meier; Jinhong Chang; Rongji Chen; Michal Jarnik; Emmanuelle Nicolas; Volker Bruss; John Taylor
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

5.  Transcription of hepatitis delta virus RNA by RNA polymerase II.

Authors:  Jinhong Chang; Xingcao Nie; Ho Eun Chang; Ziying Han; John Taylor
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

6.  Molecular and clinical aspects of hepatitis D virus infections.

Authors:  Elham Shirvani Dastgerdi; Ulf Herbers; Frank Tacke
Journal:  World J Virol       Date:  2012-06-12

Review 7.  Life cycle and pathogenesis of hepatitis D virus: A review.

Authors:  Zaigham Abbas; Rafia Afzal
Journal:  World J Hepatol       Date:  2013-12-27

8.  Determination of the multimerization state of the hepatitis delta virus antigens in vivo.

Authors:  Cromwell T Cornillez-Ty; David W Lazinski
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Long-term therapy of chronic delta hepatitis with peginterferon alfa.

Authors:  T Heller; Y Rotman; C Koh; S Clark; V Haynes-Williams; R Chang; R McBurney; P Schmid; J Albrecht; D E Kleiner; M G Ghany; T J Liang; J H Hoofnagle
Journal:  Aliment Pharmacol Ther       Date:  2014-05-11       Impact factor: 8.171

10.  Susceptibility of human hepatitis delta virus RNAs to small interfering RNA action.

Authors:  Jinhong Chang; John M Taylor
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.